PDSB übertreffen die 25 der letzten 36Schätzungen.
69%
Nächster Bericht
Datum des nächsten Berichts
25. März 2026
Estimate forQ4 25(Revenue/ EPS)
--
/
-$0.19
Implizierte Änderung vonQ3 25(Revenue/ EPS)
--
/
--
Implizierte Änderung vonQ4 24(Revenue/ EPS)
--
/
-9.52%
PDS Biotechnology Corporation Common Stock earnings per share and revenue
On 13. Nov. 2025, PDSB reported earnings of -0.19 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 12.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -12.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.19 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were PDS Biotechnology Corporation Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, PDS Biotechnology Corporation Common Stock reported EPS of -$0.19, beating estimates by 12.68%, and revenue of $0.00, 0% as expectations.
How did the market react to PDS Biotechnology Corporation Common Stock's Q3 2025 earnings?
The stock price moved down -12.33%, changed from $0.96 before the earnings release to $0.84 the day after.
When is PDS Biotechnology Corporation Common Stock expected to report next?
The next earning report is scheduled for 25. März 2026.
What are the forecasts for PDS Biotechnology Corporation Common Stock's next earnings report?
Based on 4
analysts, PDS Biotechnology Corporation Common Stock is expected to report EPS of -$0.19 and revenue of -- for Q4 2025.